v3.19.2
Consolidated Statements Of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Operating Activities:    
Net income $ 461,366 $ 425,319
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and impairment expense 124,401 105,498
Loss (gain) on sale and retirement of assets (26,437) 4,586
Earnings of non-controlled entities (72,040) (77,048)
Distributions from operations of non-controlled entities 83,069 94,661
Equity-based incentive compensation expense 15,804 16,679
Settlement cost, amortization of prior service credit and actuarial loss 4,943 6,726
Debt prepayment costs 8,270 0
Changes in operating assets and liabilities:    
Trade accounts receivable and other accounts receivable (35,757) 24,739
Inventory 12,828 (1,233)
Accounts payable 22,110 18,843
Accrued payroll and benefits (22,880) (11,070)
Accrued interest payable (5,453) (62)
Accrued taxes other than income (4,945) (10,199)
Accrued product liabilities 977 (32,142)
Deferred revenue (9,189) 4,240
Other current and noncurrent assets and liabilities 13,493 (5,471)
Net cash provided by operating activities 570,560 564,066
Investing Activities:    
Additions to property, plant and equipment, net (487,662) (219,442)
Proceeds from sale and disposition of assets 63,887 241
Investments in non-controlled entities (112,251) (144,859)
Distributions from returns of investments in non-controlled entities 7,500 0
Deposits received from undivided joint interest third party 26,352 41,571
Net cash used by investing activities (502,174) (322,489)
Financing Activities:    
Distributions paid (457,377) (423,873)
Net commercial paper borrowings 197,000 119,896
Borrowings under long-term notes 496,855 0
Payments on notes (550,000) 0
Debt placement costs (6,817) (326)
Net payment on financial derivatives (8,028) 0
Payments associated with settlement of equity-based incentive compensation (9,764) (9,285)
Debt prepayment costs (8,270) 0
Net cash used by financing activities (346,401) (313,588)
Change in cash, cash equivalents and restricted cash (278,015) (72,011)
Cash, cash equivalents and restricted cash at beginning of period 309,261 176,068
Cash, cash equivalents and restricted cash at end of period 31,246 104,057
Supplemental non-cash investing activities:    
Additions to property, plant and equipment (514,812) (219,828)
Changes in accounts payable and other current liabilities related to capital expenditures 27,150 386
Additions to property, plant and equipment, net $ (487,662) $ (219,442)